Scientists reverse liver cell aging, cutting Alzheimer's linked protein by 50%
Escrito em English. Você está lendo em português, traduzido por IA. Como funciona
Escrito em English. Você está lendo em português, traduzido por IA. Como funciona
Dr Singularity@Dr_Singularity𝕏This is a real study, but it's an animal study, and the X post stretches it. The work is from the Keck School of Medicine of USC and was published in the Journal of Biological Chemistry (de Leve et al., 2026, "Reversing liver sinusoidal endothelial aging restores clearance of amyloid-beta and LDL"). The team gave cinaciguat to aged rats for two weeks. In those rats, blood levels of amyloid beta fell by about half, to roughly the level seen in young rats, and LDL cholesterol dropped to youthful levels too. Untreated old rats showed no such change.
What was measured: the drug reopened the tiny pores (fenestrations) in liver sinusoidal endothelial cells, the filter lining the liver's blood vessels, and restored a signal (HB-EGF) to nearby liver cells. The study measured blood levels, not brain plaques.
What it doesn't show: the authors say lowering blood amyloid beta doesn't necessarily reduce plaques in the brain or prevent Alzheimer's. They plan further rat studies to test that. The post's line about "reversing liver cell aging" and its hint at heart and brain benefits go beyond what was tested. There's no human data here.
Sources: Keck School of Medicine of USC news release and ScienceDaily's summary.
Also discussed here:
- A Drug for Hair Loss That Clears Aging Cells Instead of Blocking a …